Sino Biopharmaceutical Limited (SBHMY)
USD 8.34
(0.0%)
USD 8.34
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.06 Billion | 6.26 Billion | 5.36 Billion | 5.32 Billion | 5.32 Billion | 5.09 Billion |
| Net Income | 5.93 Billion | 5.77 Billion | 18.57 Billion | 5.01 Billion | 5.58 Billion | 11.42 Billion |
| Depreciation & Amortization | 1.07 Billion | 1.04 Billion | 992.55 Million | 1.65 Billion | 1.46 Billion | 1.17 Billion |
| Deferred income taxes | - | -649.62 Million | - | - | - | - |
| Stock-based compensation | 18.12 Million | 29.72 Million | - | - | - | - |
| Change in working capital | -430.51 Million | -195.59 Million | -339.13 Million | 261.33 Million | -278.65 Million | 243.29 Million |
| Other non-cash items | 287.91 Million | 255.05 Million | -13.85 Billion | -1.6 Billion | -1.44 Billion | -7.75 Billion |
| Investing Cash Flow | -756.97 Million | -4.07 Billion | -2.51 Billion | -7.84 Billion | -3.82 Billion | -616.1 Million |
| Investments in PPE | -1.7 Billion | -1.7 Billion | -1.89 Billion | -1.85 Billion | -1.73 Billion | -1.69 Billion |
| Acquisitions | -742.7 Million | -58.52 Million | -958.7 Million | -4.19 Billion | -221.66 Million | 1.2 Billion |
| Investment purchases | -1.65 Billion | -4.48 Billion | -4.84 Billion | -7.16 Billion | -2.89 Billion | -2.45 Billion |
| Sales/Maturities of investments | 2.56 Billion | 1.07 Billion | 903.24 Million | 5.12 Billion | 914.26 Million | 2.16 Billion |
| Other Investing Activities | -8.74 Million | 1.09 Billion | 4.28 Billion | 250.4 Million | 111.82 Million | 160.03 Million |
| Financing Cash Flow | -6.54 Billion | -3.18 Billion | -3.22 Billion | 2.23 Billion | 2.8 Billion | -2.17 Billion |
| Debt repayment | -1.71 Billion | -8.7 Billion | -2.82 Billion | -1.76 Billion | -3.19 Billion | -93.81 Million |
| Dividends payments | -632.66 Million | -1.26 Billion | -938.48 Million | -1.18 Billion | -819.68 Million | -710.32 Million |
| Common Stock Repurchased | -396.39 Million | -867.61 Million | -332.93 Million | -195.37 Million | -32.05 Million | -604.41 Million |
| Common Stock Issuance | - | 7.62 Billion | 732.8 Million | 5.35 Billion | 6.82 Billion | -796.73 Million |
| Other Financing Activities | -63.52 Million | 22.95 Million | 140.16 Million | 18.17 Million | 28.33 Million | 27.56 Million |
| Accounts receivables | -816.02 Million | -421.65 Million | -1.3 Billion | -198.78 Million | 196.3 Million | -436.2 Million |
| Accounts payables | - | 421.65 Million | 1.3 Billion | 198.78 Million | -196.3 Million | - |
| Inventory | 135.32 Million | -391.1 Million | -57.47 Million | -221.45 Million | -449.43 Million | -102.16 Million |
| Other working capital | 108.21 Million | 195.5 Million | -281.66 Million | 482.78 Million | 170.78 Million | 345.45 Million |
| Cash at beginning of period | 8.65 Billion | 9.59 Billion | 10.62 Billion | 10.63 Billion | 6.23 Billion | 3.69 Billion |
| Cash at end of period | 7.5 Billion | 8.65 Billion | 9.59 Billion | 10.62 Billion | 10.63 Billion | 6.23 Billion |
| Capital Expenditure | -1.7 Billion | -1.7 Billion | -1.89 Billion | -1.85 Billion | -1.73 Billion | -1.69 Billion |
| Effect of forex changes on cash | 90.52 Million | 47.32 Million | -649.71 Million | 280.01 Million | 95.05 Million | 242.46 Million |
| Net cash flow / Change in cash | -1.14 Billion | -944.73 Million | -1.02 Billion | -7.01 Million | 4.39 Billion | 2.54 Billion |
| Free Cash Flow | 4.36 Billion | 4.55 Billion | 3.47 Billion | 3.46 Billion | 3.59 Billion | 3.4 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 87.39 Million | 5.93 Billion | - | 181.61 Million | - | 5.77 Billion |
| Depreciation & Amortization | 51.9 Million | 1.07 Billion | - | 91.43 Million | - | 1.04 Billion |
| Deferred income taxes | - | - | - | - | - | -649.62 Million |
| Stock-based compensation | - | 18.12 Million | - | - | - | 29.72 Million |
| Change in working capital | - | -430.51 Million | - | - | - | -195.59 Million |
| Other non-cash items | 492.82 Million | 287.91 Million | - | 295.2 Million | - | 255.05 Million |
| Investing Cash Flow | 341.23 Million | -756.97 Million | - | -587.88 Million | - | -4.07 Billion |
| Investments in PPE | -126.61 Million | -1.7 Billion | - | -108.77 Million | - | -1.7 Billion |
| Acquisitions | -88.72 Million | -742.7 Million | - | 66.07 Thousand | - | -58.52 Million |
| Investment purchases | 332.13 Million | -1.65 Billion | - | -560.1 Million | - | -4.48 Billion |
| Sales/Maturities of investments | 197.94 Million | 2.56 Billion | - | 108.62 Million | - | 1.07 Billion |
| Other Investing Activities | 26.49 Million | -8.74 Million | - | -27.69 Million | - | 1.09 Billion |
| Financing Cash Flow | -255.21 Million | -6.54 Billion | - | -583.18 Million | - | -3.18 Billion |
| Debt repayment | -188.07 Million | -1.71 Billion | - | -424.61 Million | - | -8.7 Billion |
| Dividends payments | -87.41 Million | -632.66 Million | - | - | - | -1.26 Billion |
| Common Stock Repurchased | -20.76 Million | -396.39 Million | - | -34 Million | - | -867.61 Million |
| Common Stock Issuance | - | - | - | - | - | 7.62 Billion |
| Other Financing Activities | -329.35 Million | -63.52 Million | - | -124.55 Million | - | 22.95 Million |
| Accounts receivables | - | -816.02 Million | - | - | - | -421.65 Million |
| Accounts payables | - | - | - | - | - | 421.65 Million |
| Inventory | - | 135.32 Million | - | - | - | -391.1 Million |
| Other working capital | - | 108.21 Million | - | - | - | 195.5 Million |
| Cash at beginning of period | 453.46 Million | 8.65 Billion | - | 1.24 Billion | - | 9.59 Billion |
| Cash at end of period | 1.02 Billion | 7.5 Billion | - | 453.46 Million | - | 8.65 Billion |
| Capital Expenditure | -126.61 Million | -1.7 Billion | - | -108.77 Million | - | -1.7 Billion |
| Effect of forex changes on cash | - | 90.52 Million | - | - | - | 47.32 Million |
| Net cash flow / Change in cash | 576.1 Million | -1.14 Billion | - | -791.53 Million | - | -944.73 Million |
| Free Cash Flow | 401.69 Million | 4.36 Billion | - | 276.61 Million | - | 4.55 Billion |
FOX
CNFRZ
JDVB
1104
8111
CHSCL